| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $78.49B | +62.3% |
| Cost of Revenue | $33.97B | +87.1% |
| R&D Expense | $71.0M | +14.5% |
| SG&A Expense | $623.0M | -13.4% |
| Interest Expense | $805.0M | -8.9% |
| Pre-tax Income | $28.23B | +122.1% |
| Income Tax | $9.55B | +106.1% |
| Net Income | $18.68B | +131.2% |
| EPS (Basic) | $14.62 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.46B | +28.4% |
| Inventory | $1.22B | +0.9% |
| Current Assets | $18.75B | +16.8% |
| Total Assets | $93.83B | +3.5% |
| Current Liabilities | $12.85B | +6.9% |
| Long-term Debt | $16.23B | -13.4% |
| Total Liabilities | $45.83B | +1.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.31B | +66.6% |
| Investing Cash Flow | -$8.74B | -2.3% |
| Financing Cash Flow | -$18.05B | -185.0% |
| +140.1% |
| EPS (Diluted) | $14.57 | +140.0% |
| Stockholders' Equity |
| $48.00B |
| +5.7% |